|
|
|
|
Vol. 11, Issue 3, 887-896, March 2000
and
*Department of Molecular Pharmacology, Stanford University School
of Medicine, Stanford, California 94305-5332; and Xenopus oocytes and eggs provide a dramatic example
of how the consequences of p42 mitogen-activated protein kinase (p42
MAPK) activation depend on the particular context in which the
activation occurs. In oocytes, the activation of Mos, MEK, and
p42 MAPK is required for progesterone-induced Cdc2 activation, and
activated forms of any of these proteins can bring about Cdc2
activation in the absence of progesterone. However, in fertilized eggs,
activation of the Mos/MEK/p42 MAPK pathway has the opposite effect,
inhibiting Cdc2 activation and causing a G2 phase delay or arrest. In
the present study, we have investigated the mechanism and physiological significance of the p42 MAPK-induced G2 phase arrest, using
Xenopus egg extracts as a model system. We found that
Wee1-depleted extracts were unable to arrest in G2 phase in response to
Mos, and adding back Wee1 to the extracts restored their ability to
arrest. This finding formally places Wee1 downstream of Mos/MEK/p42
MAPK. Purified recombinant p42 MAPK was found to phosphorylate
recombinant Wee1 in vitro at sites that are phosphorylated in extracts.
Phosphorylation by p42 MAPK resulted in a modest (~2-fold)
increase in the kinase activity of Wee1 toward Cdc2. Titration
experiments in extracts demonstrated that a twofold increase in Wee1
activity is sufficient to cause the delay in mitotic entry seen in
Mos-treated extracts. Finally, we present evidence that the negative
regulation of Cdc2 by Mos/MEK/p42 MAPK contributes to the presence of
an unusually long G2 phase in the first mitotic cell cycle. Prematurely
inactivating p42 MAPK in egg extracts resulted in a corresponding
hastening of the first mitosis. The negative effect of p42 MAPK on Cdc2 activation may help ensure that the first mitotic cell cycle is long
enough to allow karyogamy to be accomplished successfully.
Zymed
Laboratories, South San Francisco, California 94080
Corresponding author. E-mail
address: ferrell{at}cmgm.stanford.edu.
This article has been cited by other articles:
![]() |
J. Q. Wu, D. V. Hansen, Y. Guo, M. Z. Wang, W. Tang, C. D. Freel, J. J. Tung, P. K. Jackson, and S. Kornbluth Control of Emi2 activity and stability through Mos-mediated recruitment of PP2A PNAS, October 16, 2007; 104(42): 16564 - 16569. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Philipova, J. Kisielewska, P. Lu, M. Larman, J.-Y. Huang, and M. Whitaker ERK1 activation is required for S-phase onset and cell cycle progression after fertilization in sea urchin embryos Development, February 1, 2005; 132(3): 579 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-C. Goulet, M. Chigbrow, P. Frisk, and M. A. Nelson Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells Carcinogenesis, January 1, 2005; 26(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen and D. G. Gardner Suppression of WEE1 and Stimulation of CDC25A Correlates with Endothelin-dependent Proliferation of Rat Aortic Smooth Muscle Cells J. Biol. Chem., April 2, 2004; 279(14): 13755 - 13763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Murakami, S. A. Moody, I. O. Daar, and D. K. Morrison Morphogenesis during Xenopus gastrulation requires Wee1-mediated inhibition of cell proliferation Development, February 1, 2004; 131(3): 571 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Kellogg Wee1-dependent mechanisms required for coordination of cell growth and cell division J. Cell Sci., December 15, 2003; 116(24): 4883 - 4890. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coon, A. Ball, J. Pound, S. Ap, D. Hollenback, T. White, J. Tulinsky, L. Bonham, D. K. Morrison, R. Finney, et al. Inhibition of lysophosphatidic acid acyltransferase {beta} disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells Mol. Cancer Ther., October 1, 2003; 2(10): 1067 - 1078. [Abstract] [Full Text] |
||||
![]() |
A. Harding, N. Giles, A. Burgess, J. F. Hancock, and B. G. Gabrielli Mechanism of Mitosis-specific Activation of MEK1 J. Biol. Chem., May 2, 2003; 278(19): 16747 - 16754. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Roberts, P. S. Shapiro, T. S. Nahreini, G. Pages, J. Pouyssegur, and N. G. Ahn Distinct Cell Cycle Timing Requirements for Extracellular Signal-Regulated Kinase and Phosphoinositide 3-Kinase Signaling Pathways in Somatic Cell Mitosis Mol. Cell. Biol., October 15, 2002; 22(20): 7226 - 7241. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Abrieu, M Doree, and D Fisher The interplay between cyclin-B-Cdc2 kinase (MPF) and MAP kinase during maturation of oocytes J. Cell Sci., January 1, 2001; 114(2): 257 - 267. [Abstract] [PDF] |
||||
![]() |
J. J. Smith, E. K. Evans, M. Murakami, M. B. Moyer, M. A. Moseley, G. V. Woude, and S. Kornbluth Wee1-regulated Apoptosis Mediated by the Crk Adaptor Protein in Xenopus Egg Extracts J. Cell Biol., December 18, 2000; 151(7): 1391 - 1400. [Abstract] [Full Text] [PDF] |
||||